Yanina Grant-Huerta, Chief Accounting Officer at Atara Biotherapeutics, Inc. (ATRA), sold 1,809 shares at $11.61 ($21K) on 2025-08-18, disclosed to the SEC on 2025-08-20.
Open-market sale of $21k ATRA by Chief Accounting Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $11.61 | 55 | $639 | 3.0% |
| 2 | $11.61 | 86 | $998 | 4.8% |
| 3 | $11.61 | 1,668 | $19K | 92.2% |
| Total | $11.61 avg | 1,809 | $21K | 100% |
| Filing → |
| ATRA | SELL | 2025-11-19 | $24K | — | Filing → |
| ATRA | SELL | 2025-05-20 | $15K | — | Filing → |